Therefore, screening APOE in several populations is of great importance to assess ethnicity-specific differences in the risk for AD and other pathologies influenced by the APOE genotype, such as stroke, cardiovascular diseases, and other neurodegenerative disorders [16,17]. This evidence concerns the gene APOE and Stroke.